Miles J De Blasio
Monash University
H-index: 32
Oceania-Australia
Top articles of Miles J De Blasio
A high-sucrose diet exacerbates the left ventricular phenotype in a high fat-fed streptozotocin rat model of diabetic cardiomyopathy
American Journal of Physiology-Heart and Circulatory Physiology
2023/2/1
Miles J De Blasio
H-Index: 21
Therapeutic targets of fibrosis: Translational advances and current challenges
2023/11
Miles J De Blasio
H-Index: 21
Current challenges in the treatment of cardiac fibrosis: Recent insights into the sex‐specific differences of glucose‐lowering therapies on the diabetic heart: IUPHAR Review 33
2023/11
Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathy
Iscience
2023/10/20
Miles J De Blasio
H-Index: 21
Cardiac-Selective Adiponectin Receptor Gene Therapy as a Therapeutic Target for Cardiomyopathy In A Mouse Model Of Type 2 Diabetes
Heart, Lung and Circulation
2023/7/1
The Mitochondria-Targeted Therapy AP39 Limits Injury in Induced Pluripotent Stem Cell (iPSC)-Derived Human Cardiomyocytes in a Type-2-Diabetic Milieu
Heart, Lung and Circulation
2023/7/1
Sex Differences in the Cardiac and Metabolic Phenotype Induced by a High Fat Diet—Choice of Vehicle Matters
Heart, Lung and Circulation
2023/7/1
Cardiovascular characterisation of a novel mouse model that combines hypertension and diabetes co-morbidities
Scientific Reports
2023/5/30
Sex differences in risk of cardiovascular events and mortality with sodium glucose co-transporter-2 inhibitors versus glucagon-like peptide 1 receptor agonists in Australians …
The Lancet Regional Health–Western Pacific
2023/4/1
Stephen Wood
H-Index: 39
Miles J De Blasio
H-Index: 21
Hypothyroidism impairs development of the gastrointestinal tract in the ovine fetus
Frontiers in Physiology
2023/3/3
Miles J De Blasio
H-Index: 21
Investigating potential sex-specific differences of newer glucose-lowering therapies on cardiovascular outcomes in Victorian patients with diabetes
Journal of Molecular and Cellular Cardiology
2022/12/31
Current landscape of preclinical models of diabetic cardiomyopathy
2022/11/1
Miles J De Blasio
H-Index: 21
The Relative Contribution of High Fat Diet and Hyperglycaemia and Their Combination to the Structural Phenotype of the Diabetic Heart
Heart, Lung and Circulation
2022/1/1
On the Basis of Sex: SGLT2i Confer Greater Cardioprotection Than GLP-1RAs in Australian Men, but Not Women, With Type 2 Diabetes (T2D)
Heart, Lung and Circulation
2022/1/1
The adiponectin signalling pathway-A therapeutic target for the cardiac complications of type 2 diabetes?
2022/4/1
Miles J De Blasio
H-Index: 21
Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart
Cardiovascular research
2022/1/1
Jeffrey R Erickson
H-Index: 14
Miles J De Blasio
H-Index: 21
Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition
Cardiovascular Diabetology
2021/12
Miles J De Blasio
H-Index: 21
Andrew J Murphy
H-Index: 9
Translational Approaches for Targeting Cardiovascular Complications of Diabetes
Frontiers in Pharmacology
2021/11/17
Miles J De Blasio
H-Index: 21
Andrew J Murray
H-Index: 35
Bone morphogenetic protein 7 gene delivery improves cardiac structure and function in a murine model of diabetic cardiomyopathy
Frontiers in Pharmacology
2021/10/8
Miles J De Blasio
H-Index: 21
Abstract P450: Single-cell Transcriptomic Profiling Of The Type-2 Diabetic Mouse Heart
Circulation Research
2021/9/3
Miles J De Blasio
H-Index: 21
Co-Authors
